EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy

Chen Chen, Peixin Tan, Wenqing Feng, Yuan Lei, Shushu Hu, Dehuan Xie, Yantan Liu, Chen Ren, Shasha Du

Journal of Cancer Research and Clinical Oncology · 2025

DOI: 10.1007/s00432-025-06159-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2025. Verfasst von Chen Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Southern Medical University, Guangzhou, 510515, China. Hauptthemen laut MEDLINE: Glioblastoma, Immunotherapy, Radiation Tolerance, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Projects in Guangzhou, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaImmunotherapyRadiation ToleranceBrain NeoplasmsBiomarkers, TumorHumansAnimalsPrognosisMiceFemaleMaleCell Line, TumorApoptosisExtracellular Matrix ProteinsTumor MicroenvironmentDisulfidptosis

Stichwörter der Autor:innen

DisulfidptosisGlioblastomaImmunotherapyRadiotherapyTumor microenvironment

Substanzen

Biomarkers, TumorExtracellular Matrix Proteins

Autor:innen und Institutionen

  • Southern Medical University, Guangzhou, 510515, China.
  • Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Department of Radiation Oncology, Guangdong Provincial People's Hospital, Southern Medical University, Guangzhou, China.
  • Southern Medical University, Guangzhou, 510515, China. renchen@smu.edu.cn.
  • Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. renchen@smu.edu.cn.
  • Department of Radiation Oncology, Guangdong Provincial People's Hospital, Southern Medical University, Guangzhou, China. renchen@smu.edu.cn.

Förderung

  • Science and Technology Projects in Guangzhou
  • National Natural Science Foundation of China

Zitieren

APA

Chen, C., Tan, P., Feng, W., Lei, Y., Hu, S., Xie, D., Liu, Y., Ren, C., & Du, S. (2025). Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-025-06159-0

Vancouver

Chen C, Tan P, Feng W, Lei Y, Hu S, Xie D, et al. Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy. Journal of Cancer Research and Clinical Oncology. 2025. doi:10.1007/s00432-025-06159-0

BibTeX
@article{Chen2025,
  author = {Chen, Chen and Tan, Peixin and Feng, Wenqing and Lei, Yuan and Hu, Shushu and Xie, Dehuan and Liu, Yantan and Ren, Chen and Du, Shasha},
  title = {Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2025},
  doi = {10.1007/s00432-025-06159-0}
}
Kostenlos starten →